BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28242162)

  • 1. Molecular Screening for Lynch Syndrome in Young Patients With Colorectal Adenomas.
    Mendelsohn RB; Herzog K; Shia J; Rahaman N; Stadler ZK; Shike M
    Clin Colorectal Cancer; 2017 Sep; 16(3):173-177. PubMed ID: 28242162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Routine Molecular Analysis for Lynch Syndrome Among Adenomas or Colorectal Cancer Within a National Screening Program.
    Goverde A; Wagner A; Bruno MJ; Hofstra RMW; Doukas M; van der Weiden MM; Dubbink HJ; Dinjens WNM; Spaander MCW
    Gastroenterology; 2018 Nov; 155(5):1410-1415. PubMed ID: 30063919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Mismatch Repair-Deficient Colorectal Adenoma/Polyp in Early-Onset, Advanced Cases: a Cross-Sectional Study Based on Iranian Hereditary Colorectal Cancer Registry.
    Khorram MR; Goshayeshi L; Maghool F; Bergquist R; Ghaffarzadegan K; Eslami S; Khooei A; Hoseini B
    J Gastrointest Cancer; 2021 Mar; 52(1):263-268. PubMed ID: 32193764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mismatch repair deficiency in Lynch syndrome-associated colorectal adenomas is more prevalent in older patients.
    Tanaka M; Nakajima T; Sugano K; Yoshida T; Taniguchi H; Kanemitsu Y; Nagino M; Sekine S
    Histopathology; 2016 Aug; 69(2):322-8. PubMed ID: 26826556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Features of colorectal adenomas among young patients with Lynch syndrome according to path_MMR: Results from the PRED-IdF registry.
    Alric H; Coffin E; Lekhal C; Benusiglio PR; Dhooge M; Colas C; Caron O; Cusin V; Becq A; Perez Cuadrado Robles E; Leenhardt R; Perkins G; Buecher B; Bellanger J; Rahmi G; Malka D; Laurent-Puig P; Chaussade S; Benamouzig R; Parc Y; Cellier C; Perrod G
    Dig Liver Dis; 2024 Apr; 56(4):672-678. PubMed ID: 37758611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low rate of microsatellite instability in young patients with adenomas: reassessing the Bethesda guidelines.
    Velayos FS; Allen BA; Conrad PG; Gum J; Kakar S; Chung DC; Truta B; Sleisenger MH; Kim YS; Terdiman JP
    Am J Gastroenterol; 2005 May; 100(5):1143-9. PubMed ID: 15842591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical testing of conventional adenomas for loss of expression of mismatch repair proteins in Lynch syndrome mutation carriers: a case series from the Australasian site of the colon cancer family registry.
    Walsh MD; Buchanan DD; Pearson SA; Clendenning M; Jenkins MA; Win AK; Walters RJ; Spring KJ; Nagler B; Pavluk E; Arnold ST; Goldblatt J; George J; Suthers GK; Phillips K; Hopper JL; Jass JR; Baron JA; Ahnen DJ; Thibodeau SN; Lindor N; Parry S; Walker NI; Rosty C; Young JP
    Mod Pathol; 2012 May; 25(5):722-30. PubMed ID: 22322191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of adenomas and hyperplastic polyps in mismatch repair mutation carriers among CAPP2 participants: report by the colorectal adenoma/carcinoma prevention programme 2.
    Liljegren A; Barker G; Elliott F; Bertario L; Bisgaard ML; Eccles D; Evans G; Macrae F; Maher E; Lindblom A; Rotstein S; Nilsson B; Mecklin JP; Möslein G; Jass J; Fodde R; Mathers J; Burn J; Bishop DT
    J Clin Oncol; 2008 Jul; 26(20):3434-9. PubMed ID: 18612159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor testing to identify lynch syndrome in two Australian colorectal cancer cohorts.
    Buchanan DD; Clendenning M; Rosty C; Eriksen SV; Walsh MD; Walters RJ; Thibodeau SN; Stewart J; Preston S; Win AK; Flander L; Ouakrim DA; Macrae FA; Boussioutas A; Winship IM; Giles GG; Hopper JL; Southey MC; English D; Jenkins MA
    J Gastroenterol Hepatol; 2017 Feb; 32(2):427-438. PubMed ID: 27273229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence of altered mismatch repair protein nuclear expression detected by immunohistochemistry on adenomas with high-grade dysplasia and features associated with this risk in a population-based study].
    Basterra M; Gomez M; Mercado Mdel R; Irisarri R; Amorena E; Arrospide A; Montes M; Aisa G; Cambra KI; Urman J
    Gastroenterol Hepatol; 2016 Oct; 39(8):500-7. PubMed ID: 26790715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining the adenoma burden in lynch syndrome.
    Kalady MF; Kravochuck SE; Heald B; Burke CA; Church JM
    Dis Colon Rectum; 2015 Apr; 58(4):388-92. PubMed ID: 25751794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of immunohistochemistry for mismatch repair proteins on colorectal polyps in the familial cancer clinic.
    Dow E; Buchanan DD; Winship IM
    Intern Med J; 2018 Nov; 48(11):1325-1330. PubMed ID: 29717530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yield of Lynch Syndrome Surveillance for Patients With Pathogenic Variants in DNA Mismatch Repair Genes.
    Goverde A; Eikenboom EL; Viskil EL; Bruno MJ; Doukas M; Dinjens WNM; Dubbink EJ; van den Ouweland AMW; Hofstra RMW; Wagner A; Spaander MCW
    Clin Gastroenterol Hepatol; 2020 May; 18(5):1112-1120.e1. PubMed ID: 31470178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic immunohistochemical screening for Lynch syndrome in colorectal cancer: a single centre experience of 486 patients.
    Zumstein V; Vinzens F; Zettl A; Heinimann K; Koeberle D; von Flüe M; Bolli M
    Swiss Med Wkly; 2016; 146():w14315. PubMed ID: 27152634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-center study of Lynch syndrome screening in colorectal polyps.
    Zhu F; Pan D; Zhang H; Ye Q; Xu P; Pan J
    Hered Cancer Clin Pract; 2019; 17():9. PubMed ID: 30918532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer.
    Lu KH; Schorge JO; Rodabaugh KJ; Daniels MS; Sun CC; Soliman PT; White KG; Luthra R; Gershenson DM; Broaddus RR
    J Clin Oncol; 2007 Nov; 25(33):5158-64. PubMed ID: 17925543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.
    Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A
    J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colonoscopy findings in high-risk individuals compared to an average-risk control population.
    Forsberg A; Kjellström L; Andreasson A; Jaramillo E; Rubio CA; Björck E; Agréus L; Talley NJ; Lindblom A
    Scand J Gastroenterol; 2015 Jul; 50(7):866-74. PubMed ID: 25762374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mismatch repair deficiency concordance between primary colorectal cancer and corresponding metastasis.
    Haraldsdottir S; Roth R; Pearlman R; Hampel H; Arnold CA; Frankel WL
    Fam Cancer; 2016 Apr; 15(2):253-60. PubMed ID: 26666765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of Lynch syndrome in consecutive patients with colorectal cancer.
    Green RC; Parfrey PS; Woods MO; Younghusband HB
    J Natl Cancer Inst; 2009 Mar; 101(5):331-40. PubMed ID: 19244167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.